However, the present findings confirm our previous results of multiple regression analysis showing that diagnosis of PM or DM was less discriminatory for BAFF levels than the presence of anti-Jo-1 antibodies or lung involvement, and explaining higher serum BAFF levels in myositis-associated ILD by the presence of anti-Jo-1 antibodies [17]. This evidence concerns the gene TNFSF13B and interstitial lung disease.